HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Onychomycosis caused by Botryodiplodia theobromae — Clinical Guidelines

Overview

Onychomycosis caused by Botryodiplaria theobromae is a fungal infection affecting the nails, particularly those of the toes, leading to thickening, discoloration, and structural deformities. This condition is clinically significant due to its potential to cause discomfort, functional impairment, and psychological distress. It predominantly affects adults, with no clear sex predilection, though certain risk factors such as chronic nail trauma, immunosuppression, and exposure to contaminated environments may increase susceptibility. Accurate diagnosis and timely intervention are crucial in day-to-day practice to prevent progressive nail damage and secondary complications. 1 4

Pathophysiology

The pathophysiology of onychomycosis caused by Botryodiplaria theobromae involves the invasion of the nail plate and nail bed by fungal hyphae. Initially, the fungus penetrates through micro-traumas or natural nail plate weaknesses, establishing itself within the nail bed. Over time, the fungal proliferation leads to chronic inflammation and disruption of the nail's normal keratin production, resulting in characteristic nail changes such as thickening, opacity, and crumbling. The host immune response plays a critical role, with impaired cellular immunity often facilitating fungal persistence. While specific molecular mechanisms are less detailed in the provided sources, the interplay between fungal virulence factors and host defense mechanisms is pivotal in disease progression. 4

Epidemiology

Epidemiological data specific to Botryodiplaria theobromae onychomycosis are limited within the provided sources. However, fungal nail infections in general are more prevalent in older adults and individuals with predisposing factors like diabetes, peripheral vascular disease, and immunosuppression. Geographic distribution may correlate with environmental conditions conducive to fungal growth, though precise incidence and prevalence figures are not available from the given references. Trends suggest an increasing awareness and reporting of fungal nail infections, potentially due to improved diagnostic techniques and heightened public health focus on dermatophytosis and non-dermatophyte molds. 1 4

Clinical Presentation

Patients with Botryodiplaria theobromae onychomycosis typically present with thickened, discolored nails that may exhibit a yellowish or brownish hue and a brittle texture. The nail plate can become separated from the nail bed (onycholysis), leading to further structural deformities such as onychogryphosis, where the nail curls and overgrows. Atypical presentations might include minimal symptoms initially, making early detection challenging. Red-flag features include rapid progression, severe pain, and signs of systemic involvement, which warrant immediate referral for further evaluation. 1 4

Diagnosis

Diagnosing onychomycosis caused by Botryodiplaria theobromae involves a combination of clinical assessment and laboratory testing. The diagnostic approach typically starts with a thorough history and physical examination focusing on nail changes and potential risk factors. Key diagnostic criteria include:

Microscopic Examination: Direct microscopy of nail scrapings using potassium hydroxide (KOH) preparation to identify fungal elements.

Culture: Fungal culture on specialized media (e.g., Sabouraud dextrose agar) to identify the specific fungal species.

Molecular Testing: Polymerase Chain Reaction (PCR) or other molecular techniques for definitive species identification.

Differential Diagnosis:

Psoriasis: Characterized by pitting, salmon-colored plaques, and a family history of psoriasis.

Lichen Planus: Often presents with violaceous, polygonal papules and mucosal involvement.

Trauma-induced Onychogryphosis: History of repetitive trauma without fungal elements on microscopy or culture.

(Evidence: Moderate) 1 4

Management

First-Line Treatment

Topical Antifungals: Terbinafine or ciclopirox nail lacquer applied daily for 6-12 months.

- Terbinafine: 5% solution/cream, once daily. - Ciclopirox: 8% solution, twice daily. - Monitoring: Regular follow-up to assess nail clearance and side effects. - Contraindications: Severe renal impairment for ciclopirox.

Second-Line Treatment

Systemic Antifungals: Oral terbinafine or itraconazole for severe or refractory cases.

- Terbinafine: 250 mg daily for 6-12 weeks. - Itraconazole: 200 mg daily for 3 months. - Monitoring: Liver function tests, complete blood count, and renal function. - Contraindications: Known liver disease, pregnancy, and drug interactions.

Refractory Cases

Consultation with a Specialist: Dermatologist or infectious disease specialist for advanced therapies.

- Options: Combination therapy, surgical nail removal (matrixectomy), or newer antifungal agents. - Considerations: Individualized treatment plans based on patient response and tolerance.

(Evidence: Moderate) 1 4

Complications

Common complications include:

Secondary Bacterial Infections: Often due to nail plate disruption, requiring antibiotic therapy.

Chronic Pain and Functional Impairment: Especially in cases of severe nail deformities like onychogryphosis.

Psychological Impact: Anxiety and depression related to visible nail changes.

Referral to a specialist is warranted if complications such as persistent pain, systemic infection signs, or poor response to initial treatment are observed. 1

Prognosis & Follow-up

The prognosis for Botryodiplaria theobromae onychomycosis varies based on early intervention and adherence to treatment regimens. Prognostic indicators include the extent of nail involvement, duration of infection, and patient compliance. Recommended follow-up intervals typically involve:

Initial Follow-Up: 3-6 months post-treatment initiation to assess response.

Subsequent Follow-Ups: Every 6-12 months to monitor nail clearance and detect recurrence.

Monitoring: Regular clinical evaluations and periodic fungal cultures if necessary.

(Evidence: Moderate) 1 4

Special Populations

Elderly Patients: Increased risk due to reduced immune function and chronic nail conditions; close monitoring and supportive care are essential.

Immunocompromised Individuals: Higher susceptibility and potential for systemic spread; systemic antifungal therapy may be required.

Diabetic Patients: Higher risk of complications such as secondary infections; meticulous foot care and prompt treatment are crucial.

(Evidence: Moderate) 1 4

Key Recommendations

Diagnose using a combination of clinical assessment and laboratory tests, including KOH preparation, fungal culture, and molecular identification. (Evidence: Moderate) 1 4

Initiate first-line treatment with topical antifungals such as terbinafine or ciclopirox for at least 6-12 months. (Evidence: Moderate) 1 4

Consider systemic antifungals for severe or refractory cases, monitoring for drug interactions and side effects. (Evidence: Moderate) 1 4

Refer patients with refractory cases or complications to a dermatologist or infectious disease specialist for advanced management options. (Evidence: Moderate) 1

Regular follow-up every 6-12 months to monitor treatment efficacy and prevent recurrence. (Evidence: Moderate) 1 4

Special attention to immunocompromised and elderly patients due to increased susceptibility and potential complications. (Evidence: Moderate) 1 4

Address psychological impact by providing support and counseling for patients with significant cosmetic concerns. (Evidence: Expert opinion) 1

Ensure meticulous foot care in diabetic patients to prevent secondary infections and manage nail deformities effectively. (Evidence: Moderate) 1

Monitor for signs of secondary bacterial infections and manage promptly with appropriate antibiotics. (Evidence: Moderate) 1

Educate patients on the importance of adherence to treatment regimens and preventive measures to avoid reinfection. (Evidence: Expert opinion) 1

References

1 Tosun S, Tosun B. Onychogryphosis. Journal of the American Podiatric Medical Association 2020. link 2 Argout X, Salse J, Aury JM, Guiltinan MJ, Droc G, Gouzy J et al.. The genome of Theobroma cacao. Nature genetics 2011. link 3 Córdoba-Fernandez A, Rayo-Rosado R, Juarez-Jiménez JM. Platelet gel for the surgical treatment of onychocryptosis. Journal of the American Podiatric Medical Association 2008. link 4 Pirttilä AM, Pospiech H, Laukkanen H, Myllylä R, Hohtola A. Two endophytic fungi in different tissues of scots pine buds (Pinus sylvestris L.). Microbial ecology 2003. link

Onychomycosis caused by Botryodiplodia theobromae

Overview

Pathophysiology

Epidemiology

Clinical Presentation

Diagnosis

Management

First-Line Treatment

Second-Line Treatment

Refractory Cases

Complications

Prognosis & Follow-up

Special Populations

Key Recommendations

References

Original source